Evidence map›Paper›PMID 28928160›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach.

Jing Li, Jianmei Wu, Xun Bao, Norissa Honea, Youming Xie, Seongho Kim, Alex Sparreboom, Nader Sanai

Open access · bronzeAbstract readClinical Trial, Phase I
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. UGT2B7-mediated drug-drug interaction between cannabinoids and hydromorphone.Drug metabolism and disposition: the biological fate of chemicals · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Mechanistic Modeling of Intrathecal Chemotherapy Pharmacokinetics in the Human Central Nervous System.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  17. Review
  18. KRASOncoTargets and therapy · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jing LiKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan. lijin@karmanos.org Nader.Sanai@barrowbrainandspine.com.
Jianmei WuKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Xun BaoKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Norissa HoneaBarrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona.
Youming XieKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Seongho KimKarmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan.
Alex SparreboomCollege of Pharmacy & Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.
Nader SanaiBarrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona. lijin@karmanos.org Nader.Sanai@barrowbrainandspine.com.
Barrow Neurological Institute · USSt. Joseph's Hospital and Medical Center · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA022453
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overAnimalsATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2Biological TransportBlood-Brain BarrierCell Cycle ProteinsDogsGene Expression Regulation, NeoplasticGlioblastomaHumansMadin Darby Canine Kidney CellsMiddle AgedNeoplasm ProteinsABCB1 protein, humanABCG2 protein, humanadavosertibATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily G, Member 2Cell Cycle ProteinsNeoplasm ProteinsNuclear ProteinsOrganic Anion TransportersProtein-Tyrosine KinasesPyrazolesPyrimidinesPyrimidinonesSLCO1A2 protein, humanWEE1 protein, human

Identifiers

PMID28928160
PMCPMC6097184
OpenAlexW2754610420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.